Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kia Busch, Benjamin Dahl, Stine E. Petersen, Heidi S. Rønde, Lise Bentzen, Sara Pilskog & Ludvig P. Muren. (2021) Anatomically robust proton therapy using multiple planning computed tomography scans for locally advanced prostate cancer. Acta Oncologica 60:5, pages 598-604.
Read now
Read now
L. J. Lutkenhaus, A. Vestergaard, A. Bel, M. Høyer, M. C. C. M. Hulshof, C. M. van Leeuwen, O. Casares-Magaz, J. B. Petersen, J. Søndergaard & L. P. Muren. (2016) A biological modeling based comparison of two strategies for adaptive radiotherapy of urinary bladder cancer. Acta Oncologica 55:8, pages 1009-1015.
Read now
Read now
Articles from other publishers (26)
A. V. Troianov, I. O. Dementev, I. N. Zaborsky, V. S. Chaykov, O. B. Karyakin & Yu. V. Gumenetskaya. (2023) Trimodal organ‑preserving treatment of muscle‑invasive bladder cancer. Research and Practical Medicine Journal 10:1, pages 111-125.
Crossref
Crossref
Kristopher Dennis, Kelly Linden & Marc Gaudet. (2023) A shift from simple to sophisticated: using intensity-modulated radiation therapy in conventional nonstereotactic palliative radiotherapy. Current Opinion in Supportive & Palliative Care 17:1, pages 70-76.
Crossref
Crossref
Derek Raghavan, Richard Cote, Earle F. Burgess, Derek McHaffie & Peter E. Clark. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
11
.
Lina M. Åström, Claus P. Behrens, Lucie Calmels, David Sjöström, Poul Geertsen, Lene Sonne Mouritsen, Eva Serup-Hansen, Henriette Lindberg & Patrik Sibolt. (2022) Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits. Radiotherapy and Oncology 171, pages 37-42.
Crossref
Crossref
Michael Xiang, Albert J. Chang, Karim Chamie, Alexandra Drakaki, Erqi L. Pollom, Michael L. Steinberg & Amar U. Kishan. (2022) Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer. Clinical Genitourinary Cancer 20:2, pages e94-e103.
Crossref
Crossref
Jonathan Khalifa, Stéphane Supiot, Géraldine Pignot, Christophe Hennequin, Pierre Blanchard, David Pasquier, Nicolas Magné, Renaud de Crevoisier, Pierre Graff-Cailleaud, Olivier Riou, Morgane Cabaillé, David Azria, Igor Latorzeff, Gilles Créhange, Olivier Chapet, Morgan Rouprêt, Sarah Belhomme, Arnaud Mejean, Stéphane Culine & Paul Sargos. (2021) Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder. Radiotherapy and Oncology 161, pages 95-114.
Crossref
Crossref
M. Varughese. (2021) Overcoming the Chasm Between Evidence and Routine Practice for Bladder Cancer; Just a Quixotic Notion?. Clinical Oncology 33:6, pages e274-e284.
Crossref
Crossref
Tru-Khang T. Dinh, Timur Mitin, Hilary P. Bagshaw, Karen E. Hoffman, Clara Hwang, R. Jeffrey Karnes, Amar U. Kishan, Stanley L. Liauw, Shane Lloyd, Louis Potters, Timothy N. Showalter, Al V. Taira, Neha Vapiwala, Nicholas G. Zaorsky, Anthony V. D’Amico, Paul L. Nguyen & Brian J. Davis. (2021) Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics 109:4, pages 953-963.
Crossref
Crossref
Adham Hijab, Boris Tocco, Ian Hanson, Hanneke Meijer, Christina Junker Nyborg, Anders Smedegaard Bertelsen, Robert Jan Smeenk, Gillian Smith, Jeff Michalski, Brian C. Baumann & Shaista Hafeez. (2021) MR-Guided Adaptive Radiotherapy for Bladder Cancer. Frontiers in Oncology 11.
Crossref
Crossref
J. Alfred Witjes, Harman Max Bruins, Richard Cathomas, Eva M. Compérat, Nigel C. Cowan, Georgios Gakis, Virginia Hernández, Estefania Linares Espinós, Anja Lorch, Yann Neuzillet, Mathieu Rouanne, George N. Thalmann, Erik Veskimäe, Maria J. Ribal & Antoine G. van der Heijden. (2021) European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. European Urology 79:1, pages 82-104.
Crossref
Crossref
Martin Swinton, Ananya Choudhury, Anne E. Kiltie, Peter Chung, Astrid Billfalk-Kelly, Nicholas James, Sophia C. Kamran & Jason A. Efstathiou. 2021. Bladder Cancer. Bladder Cancer
257
280
.
Michael Cardoso, Ananya Choudhury, David Christie, Thomas Eade, Farshad Foroudi, Amy Hayden, Tanya Holt, Andrew Kneebone, Giuseppe Sasso, Thomas P. Shakespeare & Mark Sidhom. (2020) FROGG patterns of practice survey and consensus recommendations on radiation therapy for MIBC. Journal of Medical Imaging and Radiation Oncology 64:6, pages 882-893.
Crossref
Crossref
Alexander D. Sherry, Adam Stewart, Guozhen Luo & Austin N. Kirschner. (2019) Intensity-modulated radiotherapy is superior to three-dimensional conformal radiotherapy in the trimodality management of muscle-invasive bladder cancer with daily cone beam computed tomography optimization. Journal of Radiation Oncology 8:4, pages 395-403.
Crossref
Crossref
Niloy Ranjan Datta, Emanuel Stutz, Emsad Puric, Brigitte Eberle, Andreas Meister, Dietmar Marder, Olaf Timm, Susanne Rogers, Stephen Wyler & Stephan Bodis. (2019) A Pilot Study of Radiotherapy and Local Hyperthermia in Elderly Patients With Muscle-Invasive Bladder Cancers Unfit for Definitive Surgery or Chemoradiotherapy. Frontiers in Oncology 9.
Crossref
Crossref
Li Tee Tan MBBS, MRCP, FRCR, MD, Kari Tanderup PhD, Christian Kirisits PhD, Astrid de Leeuw PhD, Remi Nout MD, PhD, Simon Duke MBBS, FRCR, Yvette Seppenwoolde PhD, Nicole Nesvacil PhD, Dietmar Georg PhD, Kathrin Kirchheiner PhD, Lars Fokdal MD, PhD, Alina Sturdza MD, FRCPC, Maximilian Schmid MD, Jamema Swamidas PhD, Erik van Limbergen MD, PhD, Christine Haie-Meder MD, Umesh Mahantshetty MD, Ina Jürgenliemk-Schulz MD, PhD, Jacob C. Lindegaard DM, DMSc & Richard Pötter MD. (2019) Image-guided Adaptive Radiotherapy in Cervical Cancer. Seminars in Radiation Oncology 29:3, pages 284-298.
Crossref
Crossref
Cordula Petersen & Anastasia Löser. (2019) Radiochemotherapie des Harnblasenkarzinoms. InFo Hämatologie + Onkologie 22:6, pages 23-26.
Crossref
Crossref
Richard C. Walshaw, Jamie Honeychurch, Timothy M. Illidge & Ananya Choudhury. (2017) The anti-PD-1 era — an opportunity to enhance radiotherapy for patients with bladder cancer. Nature Reviews Urology 15:4, pages 251-259.
Crossref
Crossref
. (2018) 6 - Terapia Trimodale Nel Trattamento Conservativo Della Neoplasia Vescicale. Tumori Journal 104:2_suppl, pages S23-S27.
Crossref
Crossref
Richard Pötter, Kari Tanderup, Christian Kirisits, Astrid de Leeuw, Kathrin Kirchheiner, Remi Nout, Li Tee Tan, Christine Haie-Meder, Umesh Mahantshetty, Barbara Segedin, Peter Hoskin, Kjersti Bruheim, Bhavana Rai, Fleur Huang, Erik Van Limbergen, Max Schmid, Nicole Nesvacil, Alina Sturdza, Lars Fokdal, Nina Boje Kibsgaard Jensen, Dietmar Georg, Marianne Assenholt, Yvette Seppenwoolde, Christel Nomden, Israel Fortin, Supriya Chopra, Uulke van der Heide, Tamara Rumpold, Jacob Christian Lindegaard & Ina Jürgenliemk-Schulz. (2018) The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clinical and Translational Radiation Oncology 9, pages 48-60.
Crossref
Crossref
Anesa Ahamad, Alvaro Martinez, Sharon Salenius, Rudi Ross, Jason Efstathiou & Eduardo Fernandez. (2018) Routine bladder cancer treatment dictates divergence from trial-derived regimens: Results of treatment at 44 radiotherapy centers. Urologic Oncology: Seminars and Original Investigations 36:1, pages 9.e19-9.e25.
Crossref
Crossref
Mark Korpics, Alec M. Block, Basel Altoos, Brendan Martin, Kyle Carey, James Welsh, Matthew M. Harkenrider & Abhishek A. Solanki. (2017) Maximizing survival in patients with muscle-invasive bladder cancer undergoing curative bladder-preserving radiotherapy: the impact of radiotherapy dose escalation. Journal of Radiation Oncology 6:4, pages 387-395.
Crossref
Crossref
J. Alfred Witjes, Thierry Lebret, Eva M. Compérat, Nigel C. Cowan, Maria De Santis, Harman Maxim Bruins, Virginia Hernández, Estefania Linares Espinós, James Dunn, Mathieu Rouanne, Yann Neuzillet, Erik Veskimäe, Antoine G. van der Heijden, Georgios Gakis & Maria J. Ribal. (2017) Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. European Urology 71:3, pages 462-475.
Crossref
Crossref
Derek Raghavan, Richard Cote, Earle F. Burgess, Stephen B. Riggs & Michael Haake. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
10
.
Lotte J. Lutkenhaus, Rob M. van Os, Arjan Bel & Maarten C. C. M. Hulshof. (2016) Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients. Radiation Oncology 11:1.
Crossref
Crossref
Romel Canlas, Nevin McVicar, Sandy Nakano, Hardeep Sahota, Pulkit Mahajan & Scott Tyldesley. (2016) Assessment of Adaptive Margins Using a Single Planning Computed Tomography Scan for Bladder Radiotherapy. Journal of Medical Imaging and Radiation Sciences 47:3, pages 227-234.
Crossref
Crossref
Libni Eapen. (2015) A review of the 2014 English Language publications pertinent to the treatment of invasive bladder cancer by radiotherapy. Current Opinion in Supportive & Palliative Care 9:3, pages 245-248.
Crossref
Crossref